AMNEAL PHARMACEUTICALS, INC. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities of $2.23 million as of 2021-11-02, per its 10-K filed 2023-03-03.
Discontinued › Notes
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities · last filed 2023-03-03
- 2021-11-02: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities $2.23M.
- 2021-11-01: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities $2.23M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities |
|---|---|
| 2021-11-02 | $2.23M 10-K · filed 2023-03-03 |
| 2021-11-01 | $2.23M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |